Development and evaluation of an ovine antibody-based platform for treatment of Clostridium difficile infection
about
An update on antibody-based immunotherapies for Clostridium difficile infectionA Review of Experimental and Off-Label Therapies for Clostridium difficile InfectionEquine hyperimmune serum protects mice against Clostridium difficile spore challengeA novel multivalent, single-domain antibody targeting TcdA and TcdB prevents fulminant Clostridium difficile infection in mice.Structure and function of a Clostridium difficile sortase enzymeClostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen.Post-exposure treatment of Ebola virus disease in guinea pigs using EBOTAb, an ovine antibody-based therapeutic.Recombinant antigens based on toxins A and B of Clostridium difficile that evoke a potent toxin-neutralising immune response.Antibodies for treatment of Clostridium difficile infection.Intravenous adenovirus expressing a multi-specific, single-domain antibody neutralizing TcdA and TcdB protects mice from Clostridium difficile infection.Effect of passive immunotherapy against Clostridium difficile infection: a systematic review and meta-analysis.Emerging monoclonal antibodies against Clostridium difficile infection.Development of microbeads of chicken yolk antibodies against Clostridium difficile toxin A for colonic-specific delivery.A mixture of functionally oligoclonal humanized monoclonal antibodies that neutralize Clostridium difficile TcdA and TcdB with high levels of in vitro potency shows in vivo protection in a hamster infection model.Functional significance of active site residues in the enzymatic component of the Clostridium difficile binary toxin.Clostridium difficile Toxoid Vaccine Candidate Confers Broad Protection against a Range of Prevalent Circulating Strains in a Nonclinical Setting.Immunisation of mares with binding domains of toxins A and B of Clostridium difficile elicits serum and colostral antibodies that block toxin binding.
P2860
Q26740788-C48F158A-3907-4481-BAB4-2C01BEBCE184Q30240264-CEAEB8B1-7096-49C4-8B3B-398A4EA409F3Q33865434-8740FE9B-780D-4D3B-889C-940ABB8124F3Q34315655-97245339-243C-4A4D-A17A-F8CF08A7D890Q35210713-C38EFD4B-6DC4-490D-B877-6D23575DA122Q36190012-FF81A0B2-BECB-418F-B44B-23B4B06E56D5Q37134982-5877A07C-9E0B-42B1-869A-CE00D034673FQ37671489-4F2CBFC8-777D-4005-B095-6A552C1F74AAQ38208794-DD06976D-307C-4D31-975F-EE35A103FC67Q38753004-8A8D1AF0-BA65-4250-8FC1-A9B378F357E0Q38824193-A625AE04-D1A6-4D49-BD57-2AFF10A03234Q39168914-29A76836-158E-4CB5-B74F-E57E167337A9Q41394134-F8128E1D-4D76-4168-8B3F-4C8607B69F02Q41434690-003EC8C4-B577-4758-9079-14561807D70DQ41682739-0E75C390-094B-4C45-9F75-D784FF20DA48Q54239070-932ACE5D-3F7C-414F-BFEA-1E1C9940272BQ54321930-3C6CC5B7-B716-4DC0-A622-2A1254242487
P2860
Development and evaluation of an ovine antibody-based platform for treatment of Clostridium difficile infection
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Development and evaluation of ...... lostridium difficile infection
@en
type
label
Development and evaluation of ...... lostridium difficile infection
@en
prefLabel
Development and evaluation of ...... lostridium difficile infection
@en
P2093
P2860
P356
P1476
Development and evaluation of ...... lostridium difficile infection
@en
P2093
April Roberts
Clifford Shone
Harriet Denton
Ibrahim Al-Abdulla
Joanna McGlashan
John Landon
Roger Ling
Ruth Coxon
Steve Green
P2860
P304
P356
10.1128/IAI.05684-11
P407
P577
2011-12-05T00:00:00Z